Miscellaneous Healthcare

Immuno-Biological Laboratories Co., Ltd.

6678

3671

4570

<p>ImmunoForge Co., Ltd. will participate in Bio-Europe Spring 2026 in Lisbon to engage in strategic meetings with global pharmaceutical companies and investors. The company aims to discuss its proprietary BBB Shuttle platform, LMT15, and out-licensing of its Phase 2 drugs, PF1801 and PF1804. ImmunoForge is focused on promoting collaboration and technology transfer, particularly regarding its long-acting ELP platform and CNS-targeted drug development. The company is currently accepting meeting requests for the event.</p>

prnewswire

Techno Medica Co., Ltd.

Softmax Co., Ltd. (Japan)

04:58 ETImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026

VNRX

<p>VolitionRx Limited (NYSE AMERICAN: VNRX) has appointed Medical & Biological Laboratories Co. Ltd (MBL) as a non-exclusive distributor for its Nu.Q® Discover assays in Japan. CEO Dr. Jasmine Kway expressed excitement about the collaboration, which aims to enhance access to their nucleosome-based biomarkers for drug developers and researchers. Volition anticipates significant revenue growth for Nu.Q® Discover, projecting a total accessible market of nearly $1 billion. The partnership is expected to generate interest in their assays, potentially leading to future regulatory applications in Japan.</p>

StockTitan

Volitionrx

Volition Announces the Appointment of New Distributor for Nu.Q® Discover | VNRX Stock News

Immuno-Biological Laboratories Co., Ltd.(4570.JP)

04:58 ETImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026

Volition Announces the Appointment of New Distributor for Nu.Q® Discover | VNRX Stock News